Cellulite treatment industry is evolving primarily due to partnerships between various technological advancements coupled with focus on treatment effectiveness and patient satisfaction. With the demand for least invasive and non-surgical procedures accelerating, a slew of innovations by frontrunner industry players is expected to reshape the aesthetic therapies landscape for treating cellulite.
In February 2025, Lumenis and Cynosure hosted the inaugural Cellulite Treatment Innovations Summit in Miami, Florida. To be conducted by a renowned cosmetic dermatologist, Dr. Anna Martinez who is chairing the summit, the summit focused on next-generation laser therapies and technologies, radiofrequency (RF) and ultrasound-assisted treatments. Leading clinicians, researchers, and product developers came together for the event to exchange clinical outcomes and future potential of these progressive modalities.
In March 2024, Allergan (now part of AbbVie) was honored as the Preferred Technology Partner at the International Aesthetic Medical Devices Expo in Los Angeles. The company developed a breakthrough injectable formulation, which, when combined with a new, proprietary, laser-assisted delivery system, accurately targets cellulite. This breakthrough and way of choosing right cellulite treatment has taken non-surgical cellulite reduction to new heights and generated considerable buzz within the industry.
The newest non-invasive device for minimizing cellulite, from InMode, launched in May 2024 and showcased a pairing of RF energy and acoustic wave therapy. Rather, the new platform’s infiltrative technology improves collagen stimulation and microcirculation (the blood supply flow in the skin) for enhanced prevention and the correction of dimpled appearance for overall better texture as well as tone. During the launch event, live demonstrations showed how it can achieve the best clinical results with significantly less downtime.
It was also previously announced back in February 2023, in which Cutera launched its best-in-class cellulite treatment device at the Global Aesthetics Summit in London. Utilizing multi-modal energy delivery systems, the new technology selectively targets the area of subcutaneous fat while simultaneously tightening skin layers, wholeheartedly paving the way in one of the most significant advancements of efficacy versus safety in aesthetic procedures.
Syneron Candela, announces its partnership with leading cosmetic research institute The joint venture aspires to merge artificial intelligence (AI) and data analytics with existing treatment protocols to propel personalized cellulite treatment. Through this collaboration, groundbreaking innovations are expected in cellulite treatment mechanism that could change treatment paradigms and pave the way for more tailored patient care.
This is demonstrating an active phase in the cellulite treatment industry where innovative technology and partnerships are leading the way towards more effective and non-invasive treatment options. With ongoing research and innovation, patients will be able to expect better treatment outcomes and more confidence in their appearance.
Sources:
Corporate News: Lumenis, InMode
Corporate Press Release: Cynosure. Allergan (AbbVie), Syneron Candela
